Study on the improvement effects of Compound qinbai granules on ulcerative colitis in rats and its mechanism
- VernacularTitle:复方芩柏颗粒对溃疡性结肠炎大鼠的改善作用及机制研究
- Author:
Shouyan HE
1
;
Wenpeng LUO
2
;
Liao PAN
1
;
Jinyin XIAO
3
;
Zhenquan WANG
1
Author Information
1. The Third Department of Anal and Intestinal Medicine，the Second Affiliated Hospital of Hunan University of Chinese Medicine，Changsha 410005，China
2. The Second Department of Anal and Intestinal Medicine，the Second Affiliated Hospital of Hunan University of Chinese Medicine，Changsha 410005，China
3. Graduate School，Hunan University of Chinese Medicine，Changsha 410036，China
- Publication Type:Journal Article
- Keywords:
Compound qinbai granules;
ulcerative colitis;
short-chain fatty acid;
G protein-coupled receptor
- From:
China Pharmacy
2025;36(6):686-691
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To investigate the improvement effects of Compound qinbai granules on ulcerative colitis （UC） in rats and its mechanism based on short-chain fatty acid （SCFA） and their targets G protein-coupled receptor （GPR）. METHODS Male SD rats were randomly divided into normal group （12 rats） and model group （30 rats）； the model group was given 5% dextran sulfate sodium solution to induce the UC model. Model rats were divided into the model group， positive control group [Mesalazine enteric-coated tablets 270 mg/（kg·d）] and Compound qinbai granules group [2.52 g/（kg·d）]， with 9 rats in each group. Rats in each group were orally administered with normal saline or corresponding medication twice a day， for three consecutive weeks. During intragastric administration， the general conditions of rats in each group were observed， and the disease activity index （DAI） scores were assessed after the last administration. Serum levels of pro-inflammatory cytokines （tumor necrosis factor-α， interleukin-6） and anti-inflammatory cytokines （transforming growth factor-β1， interleukin-10） were measured. Pathological changes in their colonic tissues were observed and scored. Additionally， the content of SCFA （acetic acid， propionic acid and butyric acid） in their feces as well as the protein and mRNA expressions of GPR41， GPR43 and GPR109A in colonic tissues were detected. RESULTS Compared with the normal group， rats in the model group exhibited lethargy and obvious blood in their feces； the colonic tissue structure was severely damaged， with pathological changes such as notable glandular loss， edema， and inflammatory cell infiltration visible； the serum levels of pro- inflammatory cytokines， DAI score and colonic pathology score were significantly increased， while the levels of anti-inflammatory cytokines， SCFA content， and protein and mRNA expressions of GPR41， GPR43 and GPR109A were significantly decreased or down-regulated （P＜0.01）. Compared with the model group， the general condition and pathological changes of colonic tissue in each administration group showed improvement， with significant reversal observed in the aforementioned quantitative indicators （P＜0.05 or P＜0.01）. CONCLUSIONS Compound qinbai granules can alleviate intestinal inflammation and intestinal mucosal damage in UC rats. These effects may be related to its ability to restore intestinal SCFA levels and the expression of their target GPR.
